Press Releases

HONG KONG, Sept. 02, 2026 (GLOBE NEWSWIRE) -- 3 E Network Technology Group Limited (NASDAQ:MASK) (the "Company" or "3 E Network") entered into a subscription agreement (the "Subscription Agreement") with 3E NETWORK TECHNOLOGY PTE. LTD., a company incorporated under the laws of Singapore and controlled by Dr. Tingjun Yang ("Dr. Yang"), the Company’s Chief Executive Officer and a director (the "Investor"), for a private placement (the "Private Placement") of an aggregate of 701,272 Class A ordinary shares, par value $0.0025 per share, of the Company (the "Class A Shares"), at a purchase price of $1.42598 per share, representing aggregate gross cash proceeds to the Company of $1,000,000. The

Immunome, Inc. (NASDAQ:IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at H.C. Wainwright’s 28th Annual Global Investment Conference on September 14, 2026, at 11:00 a.m. ET.Interested parties can access the live audio webcast of the presentation from the Investor Relations section of the company’s website at www.immunome.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.About Immunome, Inc.Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in

Recognition reflects Zurn Elkay’s strong performance across workforce, innovation, sustainability and financial strength Zurn Elkay Water Solutions Corporation (NYSE:ZWS) announced today it was named one of America’s Greatest Companies 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902390353/en/Zurn Elkay Water Solutions Corporation announced it was named one of America’s Greatest Companies 2026. The annual ranking, developed by Newsweek in partnership with Plant-A Insights Group, recognizes 650 U.S. companies demonstrating strong performance in financial leadership, innovation, workforce excellence and sustainabili

Stewart Information Services Corporation (NYSE:STC) today announced the acquisition of Tower Title, a leading national provider of telecommunications-focused title services. The acquisition strengthens Stewart’s National Commercial Services (NCS), specifically the company’s Energy & Infrastructure group, by adding a highly complementary infrastructure business that expands service capabilities, increases transaction volume and further diversifies the company's commercial portfolio. "Tower Title is an excellent strategic fit for Stewart and an exciting step forward in our commercial growth journey," said Fred Eppinger, Stewart CEO. "They have an impressive leadership team in place that has

Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million. CHARLOTTE, N.C., Sept. 2, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), a leading consumer wellness company, today announced that it has entered into a definitive asset purchase agreement to acquire operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The acquisition is being conducted through an assignment for the benefit of creditors (ABC) proceeding and is subject to court approval and customary closing conditions.

Combined Company to execute on AI-Driven Threat Intelligence,Collaboration and Data Security Platforms RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Four Leaf Acquisition Corporation ("Four Leaf" or "FORL") (OTC:FORL, FORLW, FORLU)), a special purpose acquisition company incorporated in Delaware, and Data443 Risk Mitigation, Inc. (OTCPK: ATDS) ("Data443" or the "Company"), a data security and privacy software company for "All Things Data Security," today provided an update on the definitive Business Combination Agreement (the "Business Combination Agreement"), dated as of August 27, 2026, among Four Leaf, FORL Merger Sub, Inc., a Nevada corporation and wholly-owned subs

Raanana, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, recently announced that it has completed contracting with the fourth and fifth clinical sites participating in its clinical study of NASARIX™ Allergy Blocker (PL-14). With the execution of these final agreements, Polyrizon has completed the contracting with all five U.S. clinical sites selected for the study, marking an important operational milestone and moves the NASARIX™ program into study execution. The planned first-in-human study is a prospective, multicenter, randomize

U.S. Treasury ADV up 15% from last AugustMetals ADV grew 48%CHICAGO, Sept. 2, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its second-highest August average daily volume (ADV) on record at 29.7 million contracts, an increase of 6% from August 2025. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume. August 2026 ADV across asset classes includes:Interest Rate ADV of 16.7 million contractsEquity Index ADV of 6.8 million contractsEnergy ADV of 2.3 million contractsAgricultural ADV of 2.2 million contractsMetals ADV of 1 million contractsForeign Exchange ADV of 730,000 contractsCryptocurrency ADV of 1

Company receives Class VI injection well draft permit from U.S. EPA Generated $1.06 of net income per share in Fiscal Q2 ’26 vs. $0.22 of net income per share in Fiscal Q2 ‘25 Reported gross profit of $53.3 million for Fiscal Q2 ’26 vs. $14.3 million in Fiscal Q2 ‘25 Reported Net Income to REX shareholders of $34.9 million in Fiscal Q2 ‘26 vs. $7.1 million in Fiscal Q2 ‘25 REX American Resources Corporation ("REX" or the "Company") (NYSE:REX), a leading ethanol production company, today announced financial and operational results for the Company’s fiscal second quarter 2026. REX American Resources’ fiscal second quarter 2026 results principally reflect its interests in six eth

Expands Customer Base and Geographic Footprint for Large and Growing MRO BusinessDistribution Solutions Group, Inc. (NASDAQ:DSGR) ("DSG" or the "Company"), a premier specialty distribution company, today announced the acquisition of American Fasteners Corp. ("American Fasteners", or "AFC"), a leading South Florida distributor of fasteners, tools, construction supplies and other industrial products.The acquisition strengthens DSG’s MRO business by expanding its customer base and presence in the attractive South Florida market while providing additional reach into export markets throughout Latin America and the Caribbean.Founded in 1981, American Fasteners has built a strong reputation for exc

Eaton expects to create 1,200 new manufacturing, electrical and operations jobs, with technical skills training Investment doubles manufacturing capacity of Eaton’s Fibrebond business for modular electrical enclosures New Arkansas facility builds on Fibrebond’s over 40 years in Minden, Louisiana, where production capacity has doubled over the past three years and Eaton continues to invest Intelligent power management company Eaton (NYSE:ETN) today announced a more than $242 million investment to expand its U.S. manufacturing footprint with a new facility in North Little Rock, Arkansas. The company expects to double its U.S. manufacturing capacity of customized electrical enclosure

SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (NASDAQ:KYNB) today announced that the company’s management will be attending and presenting at the H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026, in New York, NY. Thane Wettig, Chief Executive Officer of Kyntra Bio, will deliver a company presentation on Tuesday, September 15 at 4:00 PM ET. A live webcast of the presentation will be available here. Kyntra Bio’s management team will be available for one-on-one meetings during the conference. Interested investors should contact their representative at H.C. Wainwright. The live audio webcast of the event will also be available to invest

REDWOOD CITY, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage ultra-rare disease company focused on treating refractory hypoglycemia caused by a congenital or any acquired form of hyperinsulinism (HI), today announced that management will participate in the following investor conferences: Event: Cantor Global Healthcare ConferenceDate: September 9-11, 2026 Event: H.C. Wainwright 28th Annual Global Investment Conference Date: September 14-16, 2026 Event: Morgan Stanley 24th Annual Global Healthcare ConferenceDate: September 14-16, 2026 Management will be participating in fireside chats and one-on-one investor meetings t

PALO ALTO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today that one late-breaking oral presentation on the impact of oral infigratinib on medical complications in achondroplasia from PROPEL 3 will be shared at the Annual European Society for Paediatric Endocrinology (ESPE) Meeting 2026, taking place in Marseille, France on September 8-10, 2026. In addition to the late-breaking oral presentation, two posters and one eposter will be shared on longer-term data for oral infigratinib in achondroplasia

SAULT STE. MARIE, Ontario, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ:ASTL, TSX:ASTL) ("Algoma" or "the Company"), a leading Canadian producer of steel plate and hot-rolled sheet products, today provided an update regarding the previously announced unplanned outage at its Lake Superior Power ("LSP") generating facility. Since the Company’s August 17, 2026 update, Algoma has worked closely with the Independent Electricity System Operator ("IESO") to implement interim operating arrangements that have enabled the Company to resume electric arc furnace ("EAF") production from August 29, 2026 while the affected LSP turbine remains unavailable. The Company is currently m

WALTHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Troy Sarich as a Company advisor. Sarich brings nearly 30 years of extensive experience within global healthcare, life sciences and pharmaceutical commercialization to the advisory board, including deep expertise in data, analytics, and artificial intelligence. Sarich served as the Chief Commercial Data Science Officer at Johnson & Johnson where he advanced the company’s scientific and c

Earnings per share of $0.40, up 21.2%, on 7.1% sales growth and 10.6% operating margin Product backlog entering Q2 of $311 million, 6th consecutive quarter backlog exceeded $300 million Quarter-end cash balance of $155 million BROOKINGS, S.D., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Daktronics, Inc. (NASDAQ:DAKT) ("Daktronics" or the "Company"), a recognized industry leader in digital display and control system technology, today reported results for its fiscal 2027 first quarter, ended August 1, 2026. The first quarter of fiscal 2027 reflects a 13-week reporting period, compared with a 14-week reporting period in the prior-year first quarter. Fiscal 2027 Q1 Financial Highlights: Sales of

CLEVELAND, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2026: Cantor Global Healthcare Conference 2026: Fireside chat on Wednesday, September 9, 2026, at 8:00 a.m. ET and investor meetings.H.C. Wainwright 28th Annual Global Investment Conference: Company presentation on Tuesday, September 15, 2026, at 12:00 p.m. ET and investor meetings.Morgan Stanley 24th Annual Global Healthcare Conference: Fireside chat on Wednesday, September 16, 2026, at 11:30 a.m. ET and investor meetings. Live webcasts of the fireside chats and company presentation can be

TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted multipack, featuring its first live resin gummy. This month the brand will also launch new flavors in its best-selling lineup of vape cartridges, Strawberry Banana and Sweet Citrus Punch. The new SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted gummies will be exclusively sold in the SOURZ by Spinach® Fully Blasted 10-pack, Canada’s No. 1 edible multipack as of June 20261. The popular Blue Raspberry Lemonade flavor features the same bold

REHOVOT, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy platform designed to maximize anti-cancer activity while minimizing toxicity, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering tri-specific antibody constructs and methods of use. The patent allowance further expands the Company's intellectual property portfolio supporting its proprietary CAPTN-3 platform for conditionally activated multispecific antibodies. The newly allowed U.S. patent strengthens protection f